News – Page 1099 – Endpoints News

WATCH: Scott Gottlieb vows to shake up the FDA, backing a trend toward faster drug development

8 years ago

Onxeo shares blitzed after PhIII liver cancer study flops

8 years ago

Struggling in R&D, GSK lines up an FDA pitch on COPD with mixed data

8 years ago

AbbVie stirs safety jitters after two patients die in ABT-494 study

8 years ago

Regeneron, Sanofi post good PhIII asthma data for Dupixent — but it’s losing its halo

8 years ago

Summit wins $62M BARDA contract, shares surge; Novartis adds new CGRP data

8 years ago

#ESMO17 roundup: Idera shares spike on early TLR9 combo data; Erytech touts pancreatic cancer PhIIb data

8 years ago

Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn't refuse, including $20M in cash

8 years ago

#ESMO17: Roche extends losing streak with a setback for Zelboraf as Novartis combo surges ahead

8 years ago

J&J scraps a multibillion-dollar hepatitis C program after rivals divvy up the market

8 years ago

#ESMO17: Bristol-Myers posts data on an upset checkpoint combo victory in frontline kidney cancer

8 years ago

#ESMO17: Eli Lilly sets the stage for a CDK 4/6 showdown with Pfizer, Novartis — but not exactly to its advantage

8 years ago

Allergan CEO gambles a multibillion-dollar franchise — and his company rep — on a high-stakes bet at an Indian ...

8 years ago

#ESMO17: AstraZeneca salves stinging setback with a big win in a blockbuster segment of the lung cancer market

8 years ago

Roche gets hit with another big R&D setback as a prospective AMD blockbuster flops in PhIII

8 years ago

Prosecutors want Shkreli thrown in jail now after Facebook threat

8 years ago

The top 5 trends reshaping biopharma starts with an R&D earthquake

8 years ago

Kura shares soar on positive PhII cancer data; M&A buzz revolves back to AstraZeneca

8 years ago

Vas Narasimhan tapped to take Novartis' helm as Joe Jimenez heads to Silicon Valley

8 years ago

Replimune adds a $55M round and some expert help as it pursues next-gen oncolytics R&D

8 years ago

#ESMO17 ROUNDUP: Merck’s data on Keytruda/chemo combo for lung cancer takes early spotlight at ESMO

8 years ago

Sanofi, Regeneron earn ‘breakthrough’ status for a fast-track drug out to prove PD-1 dominance

8 years ago

Following up on Trump's orders, the FDA wants to know: which regulations and paperwork requirements need to go?

8 years ago

Hammered by critics, NewLink strikes back with positive PhII indoximod data — and shares rocket up

8 years ago

First page Previous page 1096 1097 109810991100 1101 1102 Next page Last page